See it: Closest image of Sun yet taken by NASA's Parker Solar Probe
This week, Nasa released new images taken by the spacecraft from the record-breaking close approach of the Sun, including from an instrument called WISPER. As Parker skimmed through the Sun's outer atmosphere, known as the corona, it used the Wide-Field Imager for Solar Probe (WISPR) to observe the corona and solar wind.
Nasa's Parker Solar Probe Makes Historic Christmas Eve Flight Through Sun's Atmosphere
The video below was created with images from WISPR, which shows solar wind in never-before-seen detail. According to NASA, this close-up shows what happens right after solar wind comes blasting out from the corona. It also shows multiple collisions of coronal mass ejections, or CMEs, the space weather phenomena most known for creating aurora lights on Earth.
This data could be key to understanding space weather, according to Angelos Vourlidas, the WISPR instrument scientist with Johns Hopkins Applied Physics Laboratory in Maryland.
NASA said as CMEs collide, their trajectory can change, making space weather forecasting more difficult to predict if these charged particles are headed for Earth.
Still, scientists do not know how solar wind is created.
"The big unknown has been: how is the solar wind generated, and how does it manage to escape the Sun's immense gravitational pull?" said Nour Rawafi, the project scientist for Parker Solar Probe at the Johns Hopkins Applied Physics Laboratory. "Understanding this continuous flow of particles, particularly the slow solar wind, is a major challenge, especially given the diversity in the properties of these streams — but with Parker Solar Probe, we're closer than ever to uncovering their origins and how they evolve."
Parker Solar Probe was named after the heliophysist Eugene Parker, who first theorized this concept in 1958. Parker was at the launch of the spacecraft with his namesake in 2018. He passed away at 94-years-old in 2022. https://www.nasa.gov/news-release/nasa-mourns-passing-of-visionary-heliophysicist-eugene-parker/Original article source: See it: Closest image of Sun yet taken by NASA's Parker Solar Probe
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders
Biohaven Ltd. (NYSE:BHVN) is one of the Best 52-Week Low Stocks to Buy According to Analysts.. On June 10, Biohaven Ltd. (NYSE:BHVN) announced that it has started a research collaboration with Bexorg, Inc. targeting central nervous system disorders. Bexorg, which is a techbio company, has a platform that can revive and study whole human and pig brains using artificial blood. This technology helps them see how drugs affect actual brain tissue. The platform produces deep data about how genes and proteins behave in disease and health. A pharmacist in a white coat with a range of drugs on shelves behind her. Both companies will use this technology to help design and test new therapies for CNS conditions. As a result of this collaboration, two Biohaven Ltd. (NYSE:BHVN) preclinical programs will benefit from these unique brain studies. Bexorg's approach offers a big leap ahead of normal lab models. Biohaven Ltd. (NYSE:BHVN) is a biopharmaceutical company that develops and commercializes treatments for diseases in immunology, neuroscience, and oncology. While we acknowledge the potential of BHVN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
37 minutes ago
- Yahoo
EBSCO Information Services Introduces Africa Studies Source to Expand Global Scholarly Impact
~ Extensive Collection of Full-text Magazines and Journals for Africa Studies ~ IPSWICH, Mass., July 17, 2025 /PRNewswire-PRWeb/ -- Researchers across the globe looking for an authoritative resource for Africa studies will benefit from the release of Africa Studies Source from EBSCO Information Services (EBSCO). Africa Studies Source includes a vast array of scholarly full-text journals and magazines, offering detailed insights into the history, culture, politics, education, and ongoing medical and scientific research that define the African continent. Africa Studies Source offers researchers access to more than 656 magazines and journals, including 614 peer-reviewed journals. Researchers gain valuable insights from international and regional journals, all authored by leading experts in various fields. The unique resource provides coverage of a wide array of subjects including the African diaspora, African history and politics, agriculture, business and industry, cultural traditions, colonialism & human rights, economic development & globalization, education, environmental issues, foreign relations, government & politics, health & medicine, religion, and science & technology. EBSCO Information Services Senior Vice President of Research Databases Sara Earley says the new resource empowers scholars to explore the evolving narratives shaping the continent of Africa. "By providing access to a vast collection of scholarly journals, the database supports the advancement of research on Africa. Africa Studies Source is invaluable for researchers seeking in-depth insights into the continent's ongoing developments." The launch of Africa Studies Source demonstrates EBSCO's ongoing dedication to advancing global academic research with the addition of another Cultural and Area Studies resource. For more information, visit: Africa Studies Source. About EBSCO Information Services EBSCO Information Services (EBSCO) is a leading provider of online research content and cutting-edge search technologies serving libraries, healthcare and medical institutions, corporations, and government agencies worldwide. As an AI-enabled services leader, EBSCO offers comprehensive solutions from research, acquisition management, subscription services and discovery services to clinical decision support and patient care, learning, and research and development, EBSCO provides institutions with access to content and resources to serve the information and workflow needs of their users and organizations. Our commitment to AI-driven innovation positions EBSCO at the forefront of the industry, enabling us to meet the evolving needs of the information services landscape. For more information, visit the EBSCO website at: Visit our blog at EBSCOpost or follow us on X, Facebook, LinkedIn and Instagram. For more information, please contact: Karena Donnelly Sr Communications Specialist kdonnelly@ Media Contact Karena Donnelly, EBSCO Information Services, 9783566500, kdonnelly@ View original content to download multimedia: SOURCE EBSCO Information Services Sign in to access your portfolio
Medscape
an hour ago
- Medscape
Diverticular Disease Demystified: Myths, Risks & Modern Care
This transcript has been edited for clarity. Hello. I'm Dr David Johnson, professor of medicine and chief of gastroenterology at Eastern Virginia Medical School and Old Dominion University in Norfolk, Virginia. Welcome back to GI Common Concerns . Diverticulosis and diverticulitis are both incredibly common conditions. It's estimated that over 70% of people aged 80 or older who undergo colonoscopy will have diverticulosis. Approximately 4% of those will develop diverticulitis in their lifetime, and roughly 15% of those cases will be complicated disease. Patients frequently ask what they can do to prevent diverticulitis or its recurrence, and the evidence to inform such conversations has evolved in recent years. This video provides an update on where we are presently. Rethinking Dietary Causes We've long emphasized diet in the management of diverticulosis and diverticulitis, and we considered it axiomatic that patients need to avoid corn, nuts, and seeds. However, a 2008 prospective cohort study in men challenged that approach, observing no association between consuming those dietary components and the risk of developing diverticulosis or diverticular complications. Although that study was performed exclusively in men, the lifetime risk for diverticulitis is actually higher in women, at approximately 5% vs 3.1%, respectively. A recent prospective analysis published in Annals of Internal Medicine from researchers at University of North Carolina adds important insights. It used validated dietary questionnaires in a large cohort of women [who had a sister with breast cancer but did not have breast cancer themselves at enrollment]. This allowed investigators to determine incident cases of diverticulitis over time, without the risk of recall bias. Researchers identified more than 1500 incident cases of diverticulitis for nearly 415,000 patient years of follow-up. They reported no association between a primary diagnosis of diverticulitis and consumption of corn, nuts, or seeds, including fresh fruits with seeds. Similarly, there was no link between those foods and the development of complicated diverticulitis resulting in abscess surgery or fistula. Collectively, these findings indicate that our patients do not necessarily need to avoid these foods. Instead, we can advise them to adopt an anti-inflammatory diet, such as the Mediterranean diet, which this recent study in women indicated had risk-reduction benefits. My own patients find these diets very easy to follow and quite practical. Modifiable Risk Factors for Recurrence The recurrence rate for diverticulitis is notably high. Within the first year after complete recovery, 8% of patients have an episode of recurrence, and approximately 20% within 10 years. The risk increases with subsequent episodes. After a second episode, it rises to 18% at 1 year and 50% at 10 years. After a third episode, the risk for recurrence is 40% at 3 years. Therefore, it's important to identify for our patients anything they can prospectively and proactively do to prevent a recurrent episode. There are several commonsense risk factors our patients should avoid. Smoking reduction or abstinence has proven benefits. Alcoholism, but not alcohol in and of itself, is associated with a higher risk. Chronic nonsteroidal anti-inflammatory drug (NSAID) use is a known risk factor. Guidelines recommend the avoidance of regular NSAID use, although aspirin should be continued when justified for cardiac indications. Weight reduction, particularly among those with truncal obesity, seems to reduce the risk for diverticulitis. Vigorous physical activity also has an inverse, beneficial relationship for diverticulitis. Identifying all these approaches is a good, simple way to help patients going forward. Symptoms, Scans, and Supplementation The guidelines are shifting around the rush to use antibiotics for episodes of recurrence. For uncomplicated diverticulitis, antibiotics don't seem to do better than not using antibiotics. In general, we have shifted toward advising that patients adopt a clear liquid diet, avoid antibiotics, and inform us if they experience any alarm features, particularly fever or worsening pain. Exceptions to the recommendations to avoid antibiotics are made for patients who are frail, have multiple comorbidities, are immunocompromised, or have laboratory findings of severe inflammation, including C-reactive protein > 140 mg/L or a white blood count > 15,000. In such patients, antibiotics are still indicated right away. The extent of diverticulitis involvement on a CT scan would also be an indication for antibiotics. However, we don't want to rush to recommend a CT scan in all patients. This reflects our increasing awareness of the radiogenic risk of CT scans and abdominal CT scans, which I discussed in a recent video. CT scans are really overutilized, and we potentially need to take a step back in when we use them. Vitamin D status is another important factor, which I touched on in a recent article. Low vitamin D levels are associated with a higher risk for diverticulitis. I routinely check the vitamin D levels in my patients and generally recommend vitamin D supplementation, given its very low risk and potential prophylactic value in patients with a history of diverticulitis. Genetic Predisposition There's a strong genetic predisposition for diverticulitis, which we often overlook in our discussions with patients. Over 30 genetic loci have been associated with diverticulosis, and at least four seem to be associated with diverticulitis. This is key when considering patients with a family history of diverticulitis, including their siblings. In monozygotic twins, the risk is higher than in dizygotic twins, accounting for about 50% of the recurrence risk for diverticulitis. We need to be proactive when asking about family history in order to identify patients who are at greater risk for disease development or recurrence. Lastly, I always tell my patients that intermittent, lingering symptoms, such as cramping, are quite common. About 45% of patients experience intermittent symptoms after recovery, which is mostly attributable to visceral hypersensitivity. There may also be a microbiome-related explanation for motility-related muscular changes related to diverticular disease. We can assure patients that they don't need to be alarmed by such symptoms, nor must they seek out immediate help from their healthcare provider. These symptoms are different from the acute and persistent worsening pain typified for diverticulitis. Instead, we can consider treating them with antispasmodics or low-dose antidepressants to manage their symptoms. I hope this overview gives you practical, evidence-based tools for discussing the management of diverticular disease with your patients. These conversations can be a lot more meaningful when supported by the latest data, allowing us all to do a better job. I'm Dr David Johnson. Thanks for listening, and I look forward to chatting with you again soon.
